Ian Nivison‐Smith

1.6k total citations
39 papers, 868 citations indexed

About

Ian Nivison‐Smith is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Ian Nivison‐Smith has authored 39 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 12 papers in Public Health, Environmental and Occupational Health and 9 papers in Oncology. Recurrent topics in Ian Nivison‐Smith's work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Lymphoblastic Leukemia research (12 papers) and Acute Myeloid Leukemia Research (9 papers). Ian Nivison‐Smith is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Acute Lymphoblastic Leukemia research (12 papers) and Acute Myeloid Leukemia Research (9 papers). Ian Nivison‐Smith collaborates with scholars based in Australia, United States and New Zealand. Ian Nivison‐Smith's co-authors include Anthony J. Dodds, Peter Smerdely, Jeff Szer, Kenneth F. Bradstock, Peter Bardy, David D.F., John J. Moore, Simon Durrant, Peter J. Shaw and Judith Trotman and has published in prestigious journals such as Blood, Stem Cells and British Journal of Haematology.

In The Last Decade

Ian Nivison‐Smith

39 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Nivison‐Smith Australia 18 360 280 164 131 121 39 868
Françoise Mazingue France 22 533 1.5× 267 1.0× 125 0.8× 512 3.9× 131 1.1× 63 1.4k
Şahika Zeynep Akı Türkiye 17 490 1.4× 285 1.0× 62 0.4× 75 0.6× 45 0.4× 71 895
Willis H. Navarro United States 15 350 1.0× 334 1.2× 75 0.5× 128 1.0× 44 0.4× 54 728
Zeynep Arzu Yeğin Türkiye 17 304 0.8× 148 0.5× 38 0.2× 69 0.5× 85 0.7× 75 744
Jonathan Cullis United Kingdom 14 746 2.1× 137 0.5× 89 0.5× 135 1.0× 61 0.5× 28 970
Jørgen Ellegaard Denmark 18 247 0.7× 112 0.4× 70 0.4× 98 0.7× 143 1.2× 51 874
F. Hernández‐Navarro Spain 21 991 2.8× 195 0.7× 61 0.4× 71 0.5× 100 0.8× 58 1.4k
Akif Yeşilipek Türkiye 21 677 1.9× 142 0.5× 72 0.4× 186 1.4× 47 0.4× 95 1.2k
Britt‐Marie Svahn Sweden 15 488 1.4× 287 1.0× 82 0.5× 137 1.0× 69 0.6× 20 850
G. Junge Switzerland 19 324 0.9× 160 0.6× 95 0.6× 62 0.5× 661 5.5× 79 1.5k

Countries citing papers authored by Ian Nivison‐Smith

Since Specialization
Citations

This map shows the geographic impact of Ian Nivison‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Nivison‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Nivison‐Smith more than expected).

Fields of papers citing papers by Ian Nivison‐Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Nivison‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Nivison‐Smith. The network helps show where Ian Nivison‐Smith may publish in the future.

Co-authorship network of co-authors of Ian Nivison‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Nivison‐Smith. A scholar is included among the top collaborators of Ian Nivison‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Nivison‐Smith. Ian Nivison‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nivison‐Smith, Ian, Samuel T. Milliken, Anthony J. Dodds, et al.. (2017). Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand. Biology of Blood and Marrow Transplantation. 24(1). 169–174. 3 indexed citations
2.
Patton, W. N., Ian Nivison‐Smith, Peter Bardy, et al.. (2016). Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation. 23(1). 147–152. 4 indexed citations
3.
Nath, Christa E., Judith Trotman, Campbell Tiley, et al.. (2016). High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation. British Journal of Clinical Pharmacology. 82(1). 149–159. 41 indexed citations
4.
Granger, Emily, et al.. (2016). Does a distal perfusion cannula reduce ischaemic complications of extracorporeal membrane oxygenation?. ANZ Journal of Surgery. 86(12). 1002–1006. 23 indexed citations
5.
Kumarasinghe, G., Andrew Parker, Ian Nivison‐Smith, et al.. (2015). Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors. The Journal of Heart and Lung Transplantation. 34(11). 1406–1414. 38 indexed citations
6.
Nivison‐Smith, Ian, et al.. (2015). A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. Biology of Blood and Marrow Transplantation. 22(2). 284–291. 27 indexed citations
7.
Ashton, Lesley J., et al.. (2014). A Population-Based Cohort Study of Late Mortality in Adult Autologous Hematopoietic Stem Cell Transplant Recipients in Australia. Biology of Blood and Marrow Transplantation. 20(7). 937–945. 9 indexed citations
8.
Ashton, Lesley J., Claire M. Vajdic, Benjamin Daniels, et al.. (2014). Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia. 29(2). 441–447. 20 indexed citations
9.
Nivison‐Smith, Ian, Judy M. Simpson, Anthony J. Dodds, et al.. (2013). A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma. Leukemia & lymphoma. 54(8). 1671–1676. 9 indexed citations
10.
Bryant, Adam, Ian Nivison‐Smith, Anna Kalff, et al.. (2013). Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients. Bone Marrow Transplantation. 49(1). 17–23. 10 indexed citations
11.
Nivison‐Smith, Ian, Anthony J. Dodds, Peter Ganly, et al.. (2011). Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998–2006: factors associated with improved survival outcome. Leukemia & lymphoma. 52(9). 1727–1735. 7 indexed citations
12.
Pant, Shubham, Mehdi Hamadani, Anthony J. Dodds, et al.. (2009). Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia. British Journal of Haematology. 148(4). 623–626. 2 indexed citations
13.
Moore, John J., Ian Nivison‐Smith, Kim‐Leng Goh, et al.. (2007). Equivalent Survival for Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 13(5). 601–607. 70 indexed citations
14.
Nivison‐Smith, Ian, Kenneth F. Bradstock, Anthony J. Dodds, et al.. (2007). Hematopoietic Stem Cell Transplantation in Australia and New Zealand, 1992-2004. Biology of Blood and Marrow Transplantation. 13(8). 905–912. 24 indexed citations
15.
16.
Nivison‐Smith, Ian, KF Bradstock, Jeff Szer, et al.. (2001). Allogeneic haemopoietic cell transplants in Australia, 1996 – A multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Bone Marrow Transplantation. 28(1). 21–27. 13 indexed citations
17.
Nivison‐Smith, Ian, et al.. (2001). Prevalence of malnutrition and 12‐month incidence of mortality in two Sydney teaching hospitals. Internal Medicine Journal. 31(8). 455–461. 164 indexed citations
18.
Atkinson, K, Ian Nivison‐Smith, Anthony J. Dodds, et al.. (1998). A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Bone Marrow Transplantation. 21(7). 691–695. 26 indexed citations
19.
Atkinson, K, Keith Fay, Ian Nivison‐Smith, & K Downs. (1997). Lenograstim administration to HLA-identical donor–recipient pairs to accelerate marrow recovery post-transplant. Bone Marrow Transplantation. 19(1). 15–21. 6 indexed citations
20.
Barclay, Lesley, et al.. (1996). Maternal Country of Origin and Infant Birthplace: Implications for Birth‐weight. Australian and New Zealand Journal of Obstetrics and Gynaecology. 36(4). 430–434. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Françoise Mazingue Breakdown of academic impact, for papers by Şahika Zeynep Akı Breakdown of academic impact, for papers by Willis H. Navarro Breakdown of academic impact, for papers by Zeynep Arzu Yeğin Breakdown of academic impact, for papers by Jonathan Cullis Breakdown of academic impact, for papers by Jørgen Ellegaard Breakdown of academic impact, for papers by F. Hernández‐Navarro Breakdown of academic impact, for papers by Akif Yeşilipek Breakdown of academic impact, for papers by Britt‐Marie Svahn Breakdown of academic impact, for papers by G. Junge
Rankless by CCL
2026